Annual Congress Berlin 2001

Saturday, 22.09.2001
Sunday, 23.09.2001
Monday, 24.09.2001
Tuesday, 25.09.2001
Wednesday, 26.09.2001

Citations should be made in the following way: Authors. Title. Eur Respir J 2004; 18: Suppl. 33, abstract number.

Material from 2001:

3025 Abstracts

Material from 2001: Show

Inflammatory and genetic mechanisms in pulmonary fibrosis

Thematic Poster Session
Chairs: R. Chambers (London, United Kingdom), P. L. Haslam (London, UK)

Download all media

Exhaled 8-isoprostane as a noninvasive marker of oxidative stress in patients with cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis N. Isola, S. A. Kharitonov, A. U. Wells, R. M. du Bois, P. J. Barnes (London, United Kingdom)
Elevated levels of serum SP-A in chronic eosinophilic pneumonia M. Abo, K. Kurashima, M. Fujimura, T. Kita, M. Yasui, K. Kasahara, S. Nakao (Kanazawa, Japan)
Predictive role of neutrophil elastase in the follow-up of patients with interstitial lung diseases E. Laserna, J. L. López-Campos, E. Rodríguez Becerra, C. Rodríguez Matute, D. Fernandez Vega, J. Castillo Gómez (Seville, Spain)
Biochemical features of bronchoalveolar lavage cells and fluid in different phases of allergic alveolitis G. O. Kaminskaya, R. Y. Abdullayev, V. P. Filippov (Moscow, Russia)
Induced sputum glutathione levels are decreased in patients with idiopathic pulmonary fibrosis K. M. Beeh, J. Beier, O. Kornmann, I. C. Haas, P. Micke, R. Buhl (Mainz, Germany)
Induced sputum (IS) MMP- 9 and TIMP- 1 in granulomatous diseases E. Fireman, J. Greif, S. Kivity, Y. Schwarz, A. Man, Z. Fireman (Tel-Aviv, Israel)
Neutrophil-rich inflammation in induced sputum of patients with idiopathic pulmonary fibrosis (IPF) J. Beier, K. M. Beeh, I. C. Haas, O. Kornmann, P. Micke, R. Buhl (Mainz, Germany)
TNFα and INFγ inducing capacity of sera from interstitial lung diseases (ILD) patients in relation to its angiogenic activity T. M. Zielonka, U. Demkow, M. Filewska, B. Bialas, E. Radzikowska, A. Soszka, P. Remiszewski, J. Szopinski, E. Wiatr, E. Skopinska-Rozewska (Warsaw, Poland)
The expression of extracellular superoxide dismutase in fibrotic disorders of human adult and newborn lung E. Lakari, R. Kaarteenaho-Wiik, Y. Soini, P. Pääkkö, V. L. Kinnula (Oulu, Finland)
Cyclo-oxygenase (Cox)-2 is not upregulated in idiopathic pulmonary fibrosis A. Xaubet, J. Mullol, J. Roca-Ferrer, L. Pujols, A. Torrego, A. Marin-Arguedas, C. Picado (Barcelona, Spain)
BAL features in patients with systemic scleroris (SSc) F. Meloni, R. Caporali, E. Paschetto, F. Bobbio-Pallavicini, A. Marone Bianco, E. Calabrò, V. Peona, L. Ratta, C. M. Montecucco (Pavia, Italy)
Enhanced expression of insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-6 in bronchoalveolar lavage cells from patients with sarcoidosis E. Parker, C. A. Bloor, R. A. Knight, M. A. Spiteri, J. T. Allen (Stoke-on-Trent, United Kingdom)
Up-regulation of γ-glutamyl-cysteine-synthetase gene expression after lung transplantation J. Behr, B. Braun, A. Neuber, C. Neurohr, M. Schwaiblmair (Munich, Germany)
Smooth muscle tissue remodelling at the development of lung fibrosis A. Zashikhin, L. Zaostrovskaia, J. Sehlin (Arkhangelsk, Russia; Umeo, Sweden)
Analysis of tumor necrosis factor receptor 1 (TNFR1) polymorphisms in patients with cryptogenic fibrosing alveolitis D. Bisirtzoglou, C. Alexopoulou, D. A. Vassilakis, K. I. Welsh, R. M. du Bois, P. Pantelidis (London, United Kingdom)
Analysis of IL-13 polymorphisms in patients with cryptogenic fibrosing alveolitis D. A. Vassilakis, C. Alexopoulou, P. I. Latsi, D. Bisirtzoglou, K. I. Welsh, R. M. du Bois, P. Pantelidis (London, United Kingdom)
IL-12 p40 subunit gene 3'UTR polymorphism analysis in CFA and sarcoidosis P. I. Latsi, H. Sato, D. A. Vassilakis, D. McGrath, K. I. Welsh, R. M. du Bois, P. Pantelidis (London, United Kingdom)